Need a specific person's email?
Browse Cara Therapeutics's employee directory (about 51 employees) and reveal verified emails free.
Cara Therapeutics's most common email format is FLast@caratherapeutics.com (ex. JDoe@caratherapeutics.com), used for 92% of caratherapeutics.com addresses. Cara Therapeutics uses 4 email patterns.
| Format | Example | Share of caratherapeutics.com |
|---|---|---|
| FLast@caratherapeutics.comMost common | JDoe@caratherapeutics.com | |
| First@caratherapeutics.com | John@caratherapeutics.com | |
| First.Last@caratherapeutics.com | John.Doe@caratherapeutics.com | |
| Last@caratherapeutics.com | Doe@caratherapeutics.com |
Browse Cara Therapeutics's employee directory (about 51 employees) and reveal verified emails free.
Biotechnology ResearchConnecticut, United States51-200 Employees
Cara Therapeutics is a mid-sized biotechnology company based in Stamford, Connecticut, focused on developing treatments for pruritus. Its portfolio includes an oral formulation of difelikefalin for chronic pruritus associated with notalgia paresthetica, pursued in a Phase 2/3 program with topline dose-finding results expected in the third quarter of 2024. Additionally, the firm has developed an intravenous difelikefalin formulation that is approved for moderate-to-severe pruritus in adults undergoing hemodialysis due to advanced chronic kidney disease, with the IV product licensed worldwide. As a development-stage player in the biotechnology research space, Cara operates with a focus on pruritus-related conditions and related therapies. In March 2025, Cara announced a merger with Tvardi Therapeutics, with completion expected in the first half of the year.
Most common format
FLast@caratherapeutics.com
Example: JDoe@caratherapeutics.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.